WD #223: A New Net-Net Buy & Don't Worry About Credit Suisse
Buying a profitable generic pharma company for less than its cash on hand, and why Credit Suisse rumors don't matter
Summary
Social media has been abuzz with rumors of a major bank failure in Europe.
There's probably nothing imminent happening. Even if there is, it's not a big deal for American investors. European banks are structurally toxic, but not an immediate hazard.
Buying Taro Pharmaceuticals at a net-net price: A profitable generic drug company selling for less t…
Keep reading with a 7-day free trial
Subscribe to Ian’s Insider Corner to keep reading this post and get 7 days of free access to the full post archives.